• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ras效应蛋白及其在有丝分裂和肿瘤发生中的作用。

Ras effectors and their role in mitogenesis and oncogenesis.

作者信息

Joneson T, Bar-Sagi D

机构信息

Department of Molecular Genetics and Microbiology, State University of New York at Stony Brook 11794, USA.

出版信息

J Mol Med (Berl). 1997 Aug;75(8):587-93. doi: 10.1007/s001090050143.

DOI:10.1007/s001090050143
PMID:9297626
Abstract

Ras proteins are membrane-bound GTP-binding proteins that play a critical role in the control of cell growth. Through a large number of genetic and biochemical studies it is becoming increasingly evident that the biological activity of Ras proteins is mediated by multiple signaling pathways. This review provides an account of the target proteins that interact with Ras and the functional consequences of these interactions. The relative contribution of the different Ras effector pathways to the mitogenic and oncogenic effects of Ras are discussed.

摘要

Ras蛋白是膜结合的GTP结合蛋白,在细胞生长控制中起关键作用。通过大量的遗传学和生物化学研究,越来越明显的是,Ras蛋白的生物学活性是由多种信号通路介导的。这篇综述介绍了与Ras相互作用的靶蛋白以及这些相互作用的功能后果。讨论了不同的Ras效应通路对Ras的促有丝分裂和致癌作用的相对贡献。

相似文献

1
Ras effectors and their role in mitogenesis and oncogenesis.Ras效应蛋白及其在有丝分裂和肿瘤发生中的作用。
J Mol Med (Berl). 1997 Aug;75(8):587-93. doi: 10.1007/s001090050143.
2
Switching to Rac and Rho.切换到Rac和Rho。
Structure. 1995 Dec 15;3(12):1281-4. doi: 10.1016/s0969-2126(01)00264-7.
3
Rho small G protein and cytoskeletal control.Rho小G蛋白与细胞骨架调控。
Princess Takamatsu Symp. 1994;24:338-50.
4
Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak.致癌性Ras通过磷脂酰肌醇3激酶、Cdc42/Rac和Pak对蛋白激酶Raf-1进行调控。
Curr Biol. 2000 Mar 9;10(5):281-4. doi: 10.1016/s0960-9822(00)00359-6.
5
Differential roles of Akt, Rac, and Ral in R-Ras-mediated cellular transformation, adhesion, and survival.Akt、Rac和Ral在R-Ras介导的细胞转化、黏附和存活中的不同作用。
Mol Cell Biol. 1999 Sep;19(9):6333-44. doi: 10.1128/MCB.19.9.6333.
6
Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.Rit是一种非脂质修饰的Ras相关蛋白,它可使NIH3T3细胞发生转化,而不激活ERK、JNK、p38丝裂原活化蛋白激酶(MAPK)或PI3K/Akt信号通路。
Oncogene. 2000 Sep 28;19(41):4685-94. doi: 10.1038/sj.onc.1203836.
7
Signaling molecules involved in coupling growth hormone receptor to mitogen-activated protein kinase activation.参与将生长激素受体与丝裂原活化蛋白激酶激活偶联的信号分子。
Endocrinology. 1997 Oct;138(10):4301-7. doi: 10.1210/endo.138.10.5453.
8
Regulation of Raf-1 kinase by TNF via its second messenger ceramide and cross-talk with mitogenic signalling.肿瘤坏死因子(TNF)通过其二信使神经酰胺对Raf-1激酶的调节以及与有丝分裂信号的相互作用。
EMBO J. 1998 Feb 2;17(3):732-42. doi: 10.1093/emboj/17.3.732.
9
Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function.含有来自Raf-1和GTP酶激活蛋白NF1的共有Ras结合序列的肽可抑制Ras功能。
Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1577-81. doi: 10.1073/pnas.93.4.1577.
10
Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells.细胞外信号调节激酶(ERK)和应激活化蛋白激酶(JNK)丝裂原活化蛋白激酶级联对HT1080纤维肉瘤细胞和DLD-1结肠癌细胞Ras转化的不同作用
Oncogene. 1999 Mar 11;18(10):1807-17. doi: 10.1038/sj.onc.1202482.

引用本文的文献

1
Cytosine base editor-mediated high-efficiency myostatin editing in Hu sheep.胞嘧啶碱基编辑器介导的湖羊肌肉生长抑制素高效编辑
Funct Integr Genomics. 2025 Aug 27;25(1):176. doi: 10.1007/s10142-025-01698-8.
2
Efficacy of chemo-immunotherapy in metastatic -mutated lung cancer: a single-center retrospective data.化疗免疫疗法在转移性KRAS突变肺癌中的疗效:单中心回顾性数据。
Front Oncol. 2024 Jan 31;14:1353491. doi: 10.3389/fonc.2024.1353491. eCollection 2024.
3
Therapeutic strategies for BRAF mutation in non-small cell lung cancer: a review.
非小细胞肺癌中BRAF突变的治疗策略:综述
Front Oncol. 2023 Aug 14;13:1141876. doi: 10.3389/fonc.2023.1141876. eCollection 2023.
4
Recent and Future Strategies to Overcome Resistance to Targeted Therapies and Immunotherapies in Metastatic Colorectal Cancer.克服转移性结直肠癌对靶向治疗和免疫治疗耐药性的近期及未来策略
J Clin Med. 2022 Dec 19;11(24):7523. doi: 10.3390/jcm11247523.
5
BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective.BRAF 突变的非小细胞肺癌:当前治疗现状与未来展望
Front Oncol. 2022 Mar 31;12:863043. doi: 10.3389/fonc.2022.863043. eCollection 2022.
6
Genetic and Genomic Pathways of Melanoma Development, Invasion and Metastasis.黑色素瘤发生、侵袭和转移的遗传及基因组通路
Genes (Basel). 2021 Sep 28;12(10):1543. doi: 10.3390/genes12101543.
7
40 Years of RAS-A Historic Overview.40 年 RAS 研究史——全面回顾
Genes (Basel). 2021 May 1;12(5):681. doi: 10.3390/genes12050681.
8
New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.对 RAS 生物学的新见解重新激发了人们对 RAS 信号数学建模的兴趣。
Semin Cancer Biol. 2019 Feb;54:162-173. doi: 10.1016/j.semcancer.2018.02.008. Epub 2018 Mar 5.
9
BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies.BRAF 突变型结直肠癌作为结直肠癌的一个独特亚组:临床特征、临床行为及对靶向治疗的反应
J Gastrointest Oncol. 2015 Dec;6(6):660-7. doi: 10.3978/j.issn.2078-6891.2015.077.
10
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.维莫非尼治疗转移性BRAF突变型结直肠癌患者的II期探索性研究
J Clin Oncol. 2015 Dec 1;33(34):4032-8. doi: 10.1200/JCO.2015.63.2497. Epub 2015 Oct 12.